Rockwell Medical Inc (RMTI.OQ)

RMTI.OQ on NASDAQ Stock Exchange Global Market

5.00USD
10:35am EDT
Price Change (% chg)

$-0.05 (-0.99%)
Prev Close
$5.05
Open
$5.08
Day's High
$5.08
Day's Low
$4.95
Volume
18,143
Avg. Vol
216,034
52-wk High
$9.50
52-wk Low
$3.16

RMTI.OQ

Chart for RMTI.OQ

About

Rockwell Medical, Inc., formerly Rockwell Medical Technologies, Inc., manufactures hemodialysis concentrate solutions and dialysis kits, and it sells, distributes and delivers these and other ancillary hemodialysis products primarily to hemodialysis providers in the United States, as well as internationally primarily in Asia,... (more)

Overall

Beta: 1.04
Market Cap (Mil.): $201.58
Shares Outstanding (Mil.): 39.92
Dividend: --
Yield (%): --

Financials

  RMTI.OQ Industry Sector
P/E (TTM): -- 37.93 37.76
EPS (TTM): -2.82 -- --
ROI: -780.23 19.48 18.76
ROE: -780.31 20.17 19.59
Search Stocks

Rockwell Medical's iron deficiency drug succeeds in trial

- Rockwell Medical Inc said a late-stage trial of its experimental iron deficiency drug met the main goal of improving hemoglobin levels in patients with chronic kidney disease.

11 Jul 2013

Rockwell Medical's iron deficiency drug succeeds in trial

July 11 - Rockwell Medical Inc said a late-stage trial of its experimental iron deficiency drug met the main goal of improving patients' hemoglobin levels.

11 Jul 2013

Rockwell Medical reports positive data on iron deficiency drug

- Rockwell Medical Inc reported positive results from a clinical study of its iron deficiency treatment for patients on hemodialysis.

04 Feb 2013

UPDATE 1-Rockwell Medical reports positive data on iron deficiency drug

Feb 4 - Rockwell Medical Inc reported positive results from a clinical study of its iron deficiency treatment for patients on hemodialysis.

04 Feb 2013

BRIEF-Rockwell Medical jumps 24 percent in premarket

NEW YORK, Feb 4 - Rockwell Medical Inc : * Shares jump 24 percent in premarket trading after drug trial results

04 Feb 2013

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: ValuEngine, Inc.
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Pechala's Reports
$25.00
Provider: S&P Capital IQ Quantitative Report
$69.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks